Two new solicitations from the NIH were released yesterday that will be of interest to the bioscience small business community. While only one uses the SBIR R43 funding mechanism the other is open to for-profit entities and those with fewer than 500 employees will be given preference. A few pertinent details on each are described below. I encourage all applicable small businesses to apply.
You will never know if you don't try
Both have a submission date of:
September 1, 2009, 5PM local time
Letters of Intent are not required but encouraged and due on:
August 3, 2008
Discuss your application with an NIH Program Manager prior to composing your proposal.
RFA-OD-09-008 Bridge Span
The purpose of this funding opportunity is to bridge the "valley of death" that occurs between research and development and market launch. This is similar to the NCI's SBIR Bridge Award. Preliminary pre-clinical work is encouraged. If you need to complete activities for regulatory filings such as an IND application these funds are for you.
A Budget of up to $1M in total costs for up to 3 years may be proposed. $35M has been committed to this funding opportunity and the NIH anticipates awarding 10 grants in FY2010.
RFA-OD-09-009 Small Business Catalyst Award
This funding opportunity uses the SBIR R43 mechanism which means it is only open to small businesses. HIgh-risk, high-return opportunities are encouraged to apply. If you are curious whether your project meets those specifications contact one of the program managers listed in the solicitation (linked above).
A Budget of up to $200K in total costs for up to 1 year may be requested. $5M has been committed to this funding opportunity and 20 to 25 awards are anticipated.
If you are a Georgia company and would like assistance with your proposal please contact us.